Stocks and Investing Stocks and Investing
Mon, May 13, 2019
Fri, May 10, 2019

Gary Nachman Maintained (AMRX) at Hold with Decreased Target to $13 on, May 10th, 2019


Published on 2024-10-26 13:39:06 - WOPRAI, Gary Nachman
  Print publication without navigation


Gary Nachman of BMO Capital, Maintained "Amneal Pharmaceuticals, Inc." (AMRX) at Hold with Decreased Target from $14 to $13 on, May 10th, 2019.

Gary, nor any peers, have made any analyst calls on AMRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources